MLEC Company Profile and Key Details

Moolec Science S.A. generated EPS of -$32.24 over the past year. Five-year average earnings growth is -583.54%. The latest quarter delivered EPS of -$0.70. The next quarter is forecast at $nan. Next year's EPS is expected at $10.53. Moolec Science S.A. earnings surprise history is a mixed track record. The quarter that ended October 01, 2025, missed forecasts by 0.0%. The prior quarter beat by 900.0%. Over the last six quarters, Apple has recorded several small beats. These include -42.86% in May 30, 2024.

Moolec Science S.A. has 4.00 million shares outstanding. The public float is 897.82 thousand shares, elevated short interest at 1.43% of float. This equals 12.39 thousand shares. The short ratio is 3.16 days. Institutional investors hold 2.89% of the float. Insiders own 21.06%.

MLEC has shown mixed momentum, gaining 6.81% over the past week and -54.97% over the past quarter, though year-to-date performance is up 14.95%. Short-term trend indicators are mixed aligned (SMA20 61.76%, SMA50 127.07%, SMA200 -58.79%). The stock’s 14-day RSI is 71.72 (overbought), while the ATR of 2.89 points to higher daily volatility. The stock remains hovering near 52-week lows, trading -90.25% below its high and over 397.97% above its low. Average 10-day trading volume of 9.86 thousand shares is below the 3-month average of 13.53 thousand, indicating normal recent market interest.

Moolec Science S.A. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around -$0.77. This means the shares are trading below this model’s fair value.

Moolec Science S.A. (NASDAQ:MLEC) closed at $6.93 USD, losing -$0.21 (-2.94%) from the previous close of $7.14. The stock is currently mid-range between its 52-week high and low $3.08 and $23.22. With a market capitalization of about $5.03 million, Moolec Science S.A. is classified as a micro-cap and shows lower-than-market volatility (beta ~0.26). Key stats such as the average daily volume over the past year has been around 12.38 thousand shares, volume is running light vs its 52-week average. Headquartered in Grand Cayman, GT, Moolec Science S.A. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Alejandro Antalich, the company employs approximately 103 people and listed since March 02, 2021. Moolec Science SA, a science-based ingredient company, engages in the development of ingredients for food, pet food, animal feed, and dietary supplements using molecular farming technology and precision fermentation platforms in Cayman Islands and internationally.

Moolec Science S.A. trades at a P/E ratio of -0.03, slightly below the S&P 500 average, with a price-to-sales ratio of 0.02 and a price-to-book ratio of -0.05 indicating negative book value, which may reflect financial stress. The P/FCF stands at -0.17, also above market averages.

Our AI price prediction model suggests that Moolec Science S.A. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -4.06%, with price expected at $6.85 by September 17, 2026, within a range of $6.38 to $7.31 3-Month Outlook: Projected fall of -96.78%, reaching $0.23 by December 02, 2026, with a range of $0.00 to $24.45. 1-Year Outlook: Projected loss of -100.0%, with price at $0.00 by September 03, 2027, within a range of $0.00 to $53.65.

Moolec Science S.A. (NASDAQ:MLEC) shares are up 14.95% year-to-date currently trading near 52-week highs band. Short-term momentum has been negative over the last quarter, despite recent volatility. Valuation shows Moolec Science S.A. trading at a premium to the broader market with a P/E of -0.03. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $5.50, suggesting -22.97% downside. Our AI forecast model points to short-term weakness (-4.06% over two weeks), a medium-term fall (-96.78% over three months), and a longer-term loss (-100.0% over one year), with expected trading ranges indicating moderate volatility.